Handbook of targeted cancer therapy / editors, Daniel D. Karp, Gerald S. Falchook.
Contributor(s): Karp, Daniel D [editor.] | Falchook, Gerald S [editor.].
Publisher: Philadelphia : Wolters Kluwer, ©2019Edition: 2nd edition.Description: 406 p.Content type: text Media type: computer Carrier type: online resourceISBN: 9781496389138; 1496389131.Other title: Targeted cancer therapy.Subject(s): Neoplasms -- drug therapy | Molecular Targeted Therapy -- methods | Antineoplastic Agents -- administration & dosage | Antineoplastic Agents -- metabolism | Antineoplastic Agents, ImmunologicalGenre/Form: Handbook. | Print books.Summary: "The exponential growth of oncology drug development and personalized/targeted therapy in the recent years has presented a challenge to even the most experienced cancer researchers. Many of us struggle to keep up with the hundreds of clinical trials conducted each year. To help with this challenge, we present here the second edition of our concise handbook intended to make the results of clinical trials of targeted cancer treatments and immunotherapy more easily accessible to cancer researchers and clinicians. We are very proud of the reception the first edition received from oncologists, medical staff, students, and even patients, and we are excited about the updated and widely expanded content included in this second edition"--Provided by publisher.| Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|
| On Shelf | RC271.C5 H375 2019 (Browse shelf) | Available | AU00000000016098 |
Includes bibliographical references and index.
Access limited to UNC Chapel Hill-authenticated users. Unlimited simultaneous users.
"The exponential growth of oncology drug development and personalized/targeted therapy in the recent years has presented a challenge to even the most experienced cancer researchers. Many of us struggle to keep up with the hundreds of clinical trials conducted each year. To help with this challenge, we present here the second edition of our concise handbook intended to make the results of clinical trials of targeted cancer treatments and immunotherapy more easily accessible to cancer researchers and clinicians. We are very proud of the reception the first edition received from oncologists, medical staff, students, and even patients, and we are excited about the updated and widely expanded content included in this second edition"--Provided by publisher.